LIBERTY AND JUSTICE FOR ALL

U

Search

Many Voices, One Freedom: United in the 1st Amendment

May 28, 2024

M

Menu

!

Menu

Your Source for Free Speech, Talk Radio, Podcasts, and News.

Featured Offer      Link to our SHOP

Print Friendly, PDF & Email

On March 21, 2024, the US FDA, led by Commissioner Robert Califf, MD, and Xavier Becerra, United States Secretary of Health and Human Services, settled a court case on their false and misleading claims concerning ivermectin in the community standard of care for COVID-19 supported by 101 studies.

During 2021, in what has been called “A War on Ivermectin,” the US FDA engaged in false and misleading tweets and public messaging to dissuade doctors, pharmacists, and patients from using the drug in The McCullough Protocol and similar multi-drug regimens for acute COVID-19.

The suit, filed by Drs Apter, Bowden, and Marik, was in the U.S. District Court for the Southern District of Texas, Galveston Division, named the U.S. Department of Health and Human Services (HHS), HHS Secretary Xavier Becerra and Dr. Robert Califf, acting FDA commissioner. The complaint alleged the FDA deceived the public on clinically appropriate, off-label use of particular drugs. Doing so, they said, is intervening in the doctor-patient relationship.

U.S. District Judge Jeffrey Brown dismissed the case in 2022 based on “sovereign immunity” and granting the FDA protection against most civil lawsuits.

But the 5th U.S. Circuit Court of Appeals in New Orleans overturned the dismissal in September 2023, ruling the agency exceeded its authority under federal law.

In our first interview, let’s listen to the reaction to this stunning development from lead Texas plaintiff Dr. Mary Talley Bowden, who is an authority on the management of acute COVID-19, vaccine injury syndromes, and routine illnesses that affect the upper airway and breathing. Bowden tells us how the settlement went down and why the FDA finally capitulated on their wrongful messaging campaign against ivermectin in 2021. Recall a similar campaign was waged against hydroxychloroquine in 2020.

The American Out Loud News platform congratulates Dr. Bowden, her co-plaintiffs Dr. Robert Apter (Emergency Medicine), Dr. Paul Marik (Pulmonary, Critical Care Medicine), and Boyden, Gray & Associates, the Washington, D.C.-based law firm, who fought against fraudulent, public deception by the US FDA.

Our second interview is with medical physician Dr. Sean Downing.  He will describe his work during the pandemic that led to a patented novel combination of drugs used to treat COVID-19 at home. You will be surprised to learn how the drug combination (Colchicine, Aspirin, and Montelukast) worked for him and his patients, providing relief through their first episode of the engineered illness from Wuhan.

Let’s get real. Let’s get loud on America Out Loud Talk Radio. This is the McCullough Report!

Downing S, Chauhan V, Chaudry IH, Galwankar S, Sharma P, Stawicki SP. Colchicine, Aspirin, and Montelukast – A Case of Successful Combined Pharmacotherapy for Adult Multisystem Inflammatory Syndrome in COVID-19. J Glob Infect Dis. 2020 Nov 30;12(4):221-224. doi: 10.4103/jgid.jgid_296_20. PMID: 33888963; PMCID: PMC8045539.

https://pubmed.ncbi.nlm.nih.gov/33888963/


The McCullough Report: Sat | Sun 2 PM ET – Internationally recognized Dr. Peter A. McCullough, known for his iconic views on the state of medical truth in America and around the globe, pierces through the thin veil of mainstream media stories that skirt the significant issues and provide no tractable basis for durable insight. Listen on iHeart Radio, our world-class media player, or our free apps on AppleAndroid, or AlexaEach episode goes to major podcast networks early in the week and can be heard on-demand anywhere in the world.

AMERICA OUT LOUD PODCAST NETWORK
AMERICA OUT LOUD PODCAST NETWORK

America Out Loud is the premier news network with a diverse array of talk shows that inform and inspire. A daily resource for smart people.

MANY VOICES, ONE FREEDOM: UNITED IN THE 1ST AMENDMENT

Join our community: Your insights matter. Contribute to the diversity of thoughts and ideas.

Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments

Sitewide Newsfeed

More Stories
.pp-sub-widget {display:none;} .walk-through-history {display:none;} .powerpress_links {display:none;} .powerpress_embed_box {display:none;}
Share via
Copy link